Keryx Biopharmaceuticals Inc fka KERX

[califax]

(YMB)... -

http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_K/threadview?m=tm&bn=10207&tid=36345&mid=36345&tof=1&frt=2

ASCO Titles Out - PERIFOSINE DATA COMING!
14-Apr-10 08:10 pm

The titles of the ASCO abstracts have been announced.
There will be two poster sessions with Perifosine featured at the early June ASCO Meeting.

1. Most notably, the final results of the randomized phase II trial comparing Xeloda+Perifosine vs. Xeloda alone will be revealed. This study and its findings led to the current large Phase III randomized study designed to explore the same comparison (and lead to a possible FDA approval). Data to be presented Tuesday, June 8th.

2. Pediatric data is now available for recurrent Pediatric solid tumors. This is a new tumor type for Perifosine with brand new, never revealed data. Poster session on Sunday, June 6th.

These two sessions may be located by visiting the "Meeting Planner" section of ASCO. Good luck to all longs!!!


http://chicago2010.asco.org/